中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性胆汁性胆管炎患者肝组织中自然杀伤细胞活化性受体及其配体的表达及意义

余海燕 韦进香 付海艳 杨依娜 涂荣芳 唐映梅

引用本文:
Citation:

原发性胆汁性胆管炎患者肝组织中自然杀伤细胞活化性受体及其配体的表达及意义

DOI: 10.3969/j.issn.1001-5256.2020.11.012
基金项目: 

国家自然科学基金(81660102,81360072); 云南省自然科学基金(2018FE001-051,2013FB050); 

详细信息
  • 中图分类号: R575.7

Expression and clinical significance of the NK cell-activating receptor NKG2D and its ligand in liver tissue of patients with primary biliary cholangitis

Research funding: 

 

  • 摘要:

    目的探讨原发性胆汁性胆管炎(PBC)中NK细胞活化性受体(NKG2D)及其配体(MICA)、相关细胞因子(IFNγ、IL-10、IL-15)表达与肝内炎症的关系。方法选取2014年8月-2015年6月在昆明医科大学第二附属医院住院且确诊为PBC(PBC组,n=30)、慢性乙型肝炎(CHB组,n=15)和非酒精性脂肪性肝病(NAFLD组,n=10)患者的肝穿刺活检标本。判断肝脏标本的肝脏炎症活动度(G)和纤维化程度(S),采用免疫组化法分别观察3组肝组织中NKG2D、MICA、IFNγ、IL-10、IL-15的表达情况(根据染色细胞多少及染色深浅计算染色评分,判断各指标表达情况)。计量资料多组间比较采用单因素方差分析,两组间比较采用t检验,相关性分析采用Spearman分析。结果 PBC组NKG2D的表达随炎症程度加重而上升,G3~4级者明显高于G1~2级者(G1vs G2 vs G3 vs G4:1.4±0.05 vs 1.56±0.05 vs 1.86±0.11 vs 2.60±0.17,F=150.8,P<0.05);随纤维化程度加重而下降(S3 vs S4:2.30±0....

     

  • [1] CHEUNG KS,SETO WK,FUNG J,et al. Epidemiology and natural history of primary biliary cholangitis in the Chinese:A territory-based study in Hong Kong between 2000 and 2015[J]. Clin Transl Gastroenterol,2017,8(8):e116.
    [2] SHIMODA S,HISAMOTO S,HARADA K,et al. Natural killer cells regulate T cell immune responses in primary biliarycirrhosis[J]. Hepatology,2016,62(6):1817-1827.
    [3] GENG X,LI M,CUI B,et al. CD4+CD25+Foxp3+regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood[J]. Medicine(Baltimore),2019,98(22):e15722.
    [4] VULETIC'A,JOVANIC'I,JURISIC'V,et al. IL-2 And IL-15 Induced NKG2D,CD158a and CD158b expression on T,NKT-like and NK cell lymphocyte subsets from regional lymph nodes of melanoma patients[J]. Pathol Oncol Res,2020,26(1):223-231.
    [5] LINDOR KD,GERSHWIN ME,POUPON R,et al. Primary biliary cirrhosis[J]. Hepatology,2009,50(1):291-308.
    [6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1958.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].临床肝胆病杂志,2015,31(12):1941-1958.
    [7] The Chinese National Work-shop on Fatty Liver and Alcoholic Liver Disease forthe Chinese Liver Disease Association. Guidelines for m anagem entofnonalcoholic fatty liver disease:An updated and revised edition[J]. J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
    [8] CHANG CH,CHEN YC,ZHANG W,et al. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis[J]. PLo S One,2015,10(3):e0121320.
    [9] SHIMODA S,HISAMOTO S,HARADA K,et al. Natural killer cells regulate T cell immune responses in primary biliary cirrhosis[J]. Hepatology,2015,62(6):1817-1827.
    [10] TANG YM,BAO WM,XIA HX,et al. Study on natural killer cells and related cytokines in liver and peripheral blood of patients with primary biliary cirrhosis[J]. Chin J Dig,2009,29(8):560-561.(in Chinese)唐映梅,包维民,夏华向,等.原发性胆汁性肝硬化患者肝脏和外周血自然杀伤细胞及其相关细胞因子的研究[J].中华消化杂志,2009,29(8):560-561.
    [11] TANG Y,BAO WM,YANG JH,et al. Expression of NKG2D/MIC in natural killer cell subsets of patients with primary biliary cirrhosis[J]. Chin J Hepatol,2015,23(8):574-579.(in Chinese)唐映梅,包维民,杨晋辉,等.原发性胆汁性肝硬化患者外周血自然杀伤细胞亚群及NKG2D/MIC表达研究[J].中华肝脏病杂志,2015,23(8):574-579.
    [12] ALLEZ M,TIENG V,NAKAZAWA A,et al. CD4+NKG2D+T cells in Crohn’s disease mediate inflammatory and cytotoxic responses through MICA interactions[J]. Gastroenterology,2007,132(7):2346-2358.
    [13] WANG XX,PAN XB,HAN JC,et al. HBs Ag stimulates NKG2D receptor expression on natural kil er cells and inhibits hepatitis C virus replication[J]. Hepatobiliary Pancreat Dis Int,2018,17(3):233-240.
    [14] LI Y,WANG JJ,GAO S,et al. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B[J]. PLo S One,2014,9(2):e86927.
    [15] BAILEY CP,BUDAK-ALPDOGAN T,SAUTER CT,et al. New interleukin-15 superagonist(IL-15SA)significantly enhances graft-versus-tumor activity[J]. Oncotarget,2017,8(27):44366-44378.
    [16] LI CD,CHEN XL,DUAN ZJ,et al. Determination of proportions of T cell subsets and levels of interleukin-15 and interleukin-16 in peripheral blood of patients with chronic hepatitis B virus infection and correlation between them[J]. J Clin Hepatol,2015,31(11):1857-1861.(in Chinese)李彩东,陈锡莲,段正军,等.慢性HBV感染者外周血T淋巴细胞亚群的变化及其与白细胞介素15、白细胞介素16的相关性分析[J].临床肝胆病杂志,2015,31(11):1857-1861.
    [17] CHEN T,ZHU L,SHI A,et al. Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B[J]. Hepatol Int,2017,11(5):419-428.
    [18] PARK JY,LEE SH,YOON SR,et al. IL-15-induced IL-10increases the cytolytic activity of human natural killer cells[J].Mol Cells,2011,32(3):265-272.
    [19] HSUEH YH,CHEN HW,SYU BJ,et al. Endogenous IL-10maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis[J]. J Autoimmun,2018,95:159-170.
    [20] CHUANG YH,LIAN ZX,TSUNEYAMA K,et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis[J]. J Autoimmun,2006,26(4):232-240.
    [21] ABULIZI A,SHAO Y,AJI T,et al. Echinococcus multilocularis inoculation induces NK cell functional decrease through high expression of NKG2A in C57BL/6 mice[J]. BMC Infect Dis,2019,19(1):792.
    [22] RAVICHANDRAN G,NEUMANN K,BERKHOUT LK,et al. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice[J]. J Hepatol,2019,71(4):773-782.
    [23] SHIMOJIMA Y,KISHIDA D,UENO KI,et al. Characteristics of circulating natural killer cells and their interferon-γproduction in active adult-onset still disease[J]. J Rheumatol,2019,46(10):1268-1276.
  • 加载中
计量
  • 文章访问数:  4546
  • HTML全文浏览量:  69
  • PDF下载量:  99
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-04-29
  • 出版日期:  2020-11-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回